CC CELGENE CORP /DE/ Stock: price and directors' dealings · United States · SEC (Form 4)Follow the CELGENE CORP /DE/ share price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). The latest transaction was filed on 16 February 2016 (Attribution). Among the most active insiders: Alles Mark J. All data is accessible without an account.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 February 2016
All Executives24 Thresholds0 Prospectus0 Other0
Declarations 24 total
◆ See Remarks · Executives · 12 Feb 2016
25,840 shares Common Stock SEC:0001209191-16-098803:0
● See Remarks · Executives · 12 Feb 2016
11,889 shares Common Stock SEC:0001209191-16-098803:1
◆ see remarks · Executives · 12 Feb 2016
29,219 shares Common Stock SEC:0001209191-16-098806:0
● see remarks · Executives · 12 Feb 2016
13,746 shares Common Stock SEC:0001209191-16-098806:1
◆ see remarks · Executives · 12 Feb 2016
1,173 shares Common Stock SEC:0001209191-16-098810:0
● see remarks · Executives · 12 Feb 2016
1,173 shares Common Stock SEC:0001209191-16-098810:1
◆ See Remarks · Executives · 12 Feb 2016
7,822 shares Common Stock SEC:0001209191-16-098814:0
● See Remarks · Executives · 12 Feb 2016
4,056 shares Common Stock SEC:0001209191-16-098814:1
◇ See Remarks · Executives · 29 Jan 2016
2,634 shares Common Stock SEC:0001209191-16-094811:0
◇ See Remarks · Executives · 29 Jan 2016
4,528 shares Common Stock SEC:0001209191-16-094811:1
◇ See Remarks · Executives · 29 Jan 2016
2,438 shares Common Stock SEC:0001209191-16-094811:2
◇ See Remarks · Executives · 29 Jan 2016
1,266 shares Common Stock SEC:0001209191-16-094811:3
◇ See Remarks · Executives · 29 Jan 2016
2,500 shares Common Stock SEC:0001209191-16-094811:4
◇ See Remarks · Executives · 29 Jan 2016
1,926 shares Common Stock SEC:0001209191-16-094811:5
◇ See Remarks · Executives · 29 Jan 2016
2,292 shares Common Stock SEC:0001209191-16-094811:6
◇ See Remarks · Executives · 29 Jan 2016
1,128 shares Common Stock SEC:0001209191-16-094811:7
◇ See Remarks · Executives · 29 Jan 2016
1,720 shares Common Stock SEC:0001209191-16-094811:8
◇ See Remarks · Executives · 29 Jan 2016
1,506 shares Common Stock SEC:0001209191-16-094811:9
◇ Director · Executives · 1 Feb 2016
18,600 shares Common Stock SEC:0001209191-16-094830:0
◇ see remarks · Executives · 15 Jan 2016
7,292 shares Common Stock SEC:0001209191-16-092291:0
◇ see remarks · Executives · 15 Jan 2016
4,030 shares Common Stock SEC:0001209191-16-092291:1
◇ see remarks · Executives · 15 Jan 2016
3,970 shares Common Stock SEC:0001209191-16-092291:2
◇ see remarks · Executives · 15 Jan 2016
3,508 shares Common Stock SEC:0001209191-16-092291:3
◇ see remarks · Executives · 15 Jan 2016
3,880 shares Common Stock SEC:0001209191-16-092291:4
关于 CELGENE CORP /DE/ CELGENE CORP /DE/ 是一家生物制药公司，专注于开发癌症和炎症性疾病药物。该公司在纳斯达克上市，股票代码为 CELG。